Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Access to PCSK9 Inhibitors.
Baum SJ, Lepor NE, Robinson JG. Baum SJ, et al. Rev Cardiovasc Med. 2018;19(S1):S47-S50. doi: 10.3909/ricm19S1S0006. Rev Cardiovasc Med. 2018. PMID: 30207557 Free article. No abstract available.
Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice.
Sabatine MS, Underberg JA, Koren M, Baum SJ. Sabatine MS, et al. Among authors: baum sj. Postgrad Med. 2016 Oct;128 Suppl 1:31-9. doi: 10.1080/00325481.2016.1208895. Epub 2016 Jul 14. Postgrad Med. 2016. PMID: 27422124
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes.
Myers KD, Farboodi N, Mwamburi M, Howard W, Staszak D, Gidding S, Baum SJ, Wilemon K, Rader DJ. Myers KD, et al. Among authors: baum sj. Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005404. doi: 10.1161/CIRCOUTCOMES.118.005404. Epub 2019 Jul 23. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31331194 Free PMC article.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
O'Donoghue ML, Rosenson RS, Gencer B, López JAG, Lepor NE, Baum SJ, Stout E, Gaudet D, Knusel B, Kuder JF, Ran X, Murphy SA, Wang H, Wu Y, Kassahun H, Sabatine MS; OCEAN(a)-DOSE Trial Investigators. O'Donoghue ML, et al. Among authors: baum sj. N Engl J Med. 2022 Nov 17;387(20):1855-1864. doi: 10.1056/NEJMoa2211023. Epub 2022 Nov 6. N Engl J Med. 2022. PMID: 36342163 Free article. Clinical Trial.
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
McCullough PA, Ballantyne CM, Sanganalmath SK, Langslet G, Baum SJ, Shah PK, Koren A, Mandel J, Davidson MH. McCullough PA, et al. Among authors: baum sj. Am J Cardiol. 2018 Apr 15;121(8):940-948. doi: 10.1016/j.amjcard.2017.12.040. Epub 2018 Feb 2. Am J Cardiol. 2018. PMID: 29472008 Free article.
108 results